WO2002061428A3 - Method of disrupting interactions between biotin and biotin-binding compounds - Google Patents
Method of disrupting interactions between biotin and biotin-binding compounds Download PDFInfo
- Publication number
- WO2002061428A3 WO2002061428A3 PCT/GB2002/000466 GB0200466W WO02061428A3 WO 2002061428 A3 WO2002061428 A3 WO 2002061428A3 GB 0200466 W GB0200466 W GB 0200466W WO 02061428 A3 WO02061428 A3 WO 02061428A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- biotin
- conjugate
- compound
- binding compounds
- disrupted
- Prior art date
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 title abstract 10
- 229960002685 biotin Drugs 0.000 title abstract 6
- 235000020958 biotin Nutrition 0.000 title abstract 6
- 239000011616 biotin Substances 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 6
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000003993 interaction Effects 0.000 title 1
- -1 biotin compound Chemical class 0.000 abstract 2
- 108090001008 Avidin Proteins 0.000 abstract 1
- 108010090804 Streptavidin Proteins 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02710163A EP1356290B1 (en) | 2001-02-01 | 2002-02-01 | Method of disrupting interactions between biotin and biotin-binding compounds |
US10/470,846 US7279285B2 (en) | 2001-02-01 | 2002-02-01 | Method of reversibly disrupting a conjugate comprising a biotin compound and a biotin-binding compound |
AT02710163T ATE553379T1 (en) | 2001-02-01 | 2002-02-01 | METHOD FOR DESTROYING INTERACTIONS BETWEEN BIOTIN AND BIOTIN-BINDING COMPOUNDS |
AU2002228214A AU2002228214B2 (en) | 2001-02-01 | 2002-02-01 | Method of disrupting interactions between biotin and biotin-binding compounds |
JP2002561943A JP4394879B2 (en) | 2001-02-01 | 2002-02-01 | Method for reversibly decomposing a complex containing a biotin compound and a compound that binds biotin |
CA2432538A CA2432538C (en) | 2001-02-01 | 2002-02-01 | Method of disrupting interactions between biotin and biotin-binding compounds |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0102568.3 | 2001-02-01 | ||
GBGB0102568.3A GB0102568D0 (en) | 2001-02-01 | 2001-02-01 | Method |
US26652401P | 2001-02-05 | 2001-02-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002061428A2 WO2002061428A2 (en) | 2002-08-08 |
WO2002061428A3 true WO2002061428A3 (en) | 2003-04-17 |
WO2002061428A8 WO2002061428A8 (en) | 2003-11-27 |
Family
ID=9907949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2002/000466 WO2002061428A2 (en) | 2001-02-01 | 2002-02-01 | Method of disrupting interactions between biotin and biotin-binding compounds |
Country Status (8)
Country | Link |
---|---|
US (1) | US7279285B2 (en) |
EP (1) | EP1356290B1 (en) |
JP (1) | JP4394879B2 (en) |
AT (1) | ATE553379T1 (en) |
AU (1) | AU2002228214B2 (en) |
CA (1) | CA2432538C (en) |
GB (1) | GB0102568D0 (en) |
WO (1) | WO2002061428A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004072258A2 (en) * | 2003-02-11 | 2004-08-26 | University Of Washington | Stimuli-responsive polymer conjugates and related methods |
DE602004018631D1 (en) | 2003-04-24 | 2009-02-05 | Afshin Ahmadian | EN |
EP2112168B1 (en) * | 2006-12-28 | 2014-10-01 | Japan Tobacco Inc. | Use of thermostable biotin-binding protein |
US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
EP2167965B1 (en) * | 2007-06-22 | 2013-04-10 | B.R.A.H.M.S GmbH | Method for detecting analytes |
DE102007044708A1 (en) * | 2007-09-18 | 2009-03-19 | Eads Deutschland Gmbh | Apparatus and method for regenerating biosensors |
US9090910B2 (en) * | 2008-07-16 | 2015-07-28 | Kbi Biopharma, Inc. | Methods and systems for manipulating particles using a fluidized bed |
KR20100122366A (en) * | 2009-05-12 | 2010-11-22 | 삼성전자주식회사 | Magnetic nanoparticles for nucleic acid sequencing and the method using the same |
US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
US20110318743A1 (en) * | 2010-06-28 | 2011-12-29 | Life Technologies Corporation | Methods, workflows, kits, apparatuses, and computer program media for nucleic acid sample preparation for nucleic acid sequencing |
WO2012159089A1 (en) * | 2011-05-19 | 2012-11-22 | Sequenom, Inc. | Products and processes for multiplex nucleic acid identification |
ES2873850T3 (en) | 2013-08-19 | 2021-11-04 | Abbott Molecular Inc | Next Generation Sequencing Libraries |
US11225658B2 (en) * | 2013-12-05 | 2022-01-18 | New England Biolabs, Inc. | Enrichment and sequencing of RNA species |
WO2016120247A1 (en) * | 2015-01-26 | 2016-08-04 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Methods for a quantitative release of biotinylated peptides and proteins from streptavidin complexes |
AU2016250849A1 (en) | 2015-04-24 | 2017-11-02 | Agena Bioscience, Inc. | Multiplex methods for detection and quantification of minor variants |
US10233489B2 (en) | 2015-04-24 | 2019-03-19 | Agena Bioscience, Inc. | Multiplexed method for the identification and quantitation of minor alleles and polymorphisms |
MA45489A (en) | 2015-10-22 | 2018-08-29 | Juno Therapeutics Gmbh | CELL CULTURE PROCESSES, ASSOCIATED KITS AND APPARATUS |
NZ758485A (en) | 2017-04-27 | 2024-02-23 | Juno Therapeutics Gmbh | Oligomeric particle reagents and methods of use thereof |
KR102653725B1 (en) | 2018-01-29 | 2024-04-01 | 세인트 쥬드 칠드런즈 리써치 호스피탈, 인코포레이티드 | Methods for Nucleic Acid Amplification |
WO2020225971A1 (en) * | 2019-05-08 | 2020-11-12 | 株式会社日立ハイテク | Automatic analysis device pretreatment method |
WO2020242856A1 (en) * | 2019-05-31 | 2020-12-03 | The Penn State Research Foundation | Specific selection of immune cells using versatile display scaffolds |
CN111676217B (en) * | 2019-09-12 | 2021-10-26 | 南京君华基因科技有限公司 | Method and system for improving nucleic acid yield and being compatible with subsequent reaction |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0456304A1 (en) * | 1990-05-04 | 1991-11-13 | Johnson & Johnson Clinical Diagnostics, Inc. | Preparation and isolation of single-stranded biotinylated nucleic acids by avidin-biotin cleavage |
JPH0578369A (en) * | 1991-08-12 | 1993-03-30 | Mitsubishi Petrochem Co Ltd | Method for separating and recovering d-biotin |
US5395856A (en) * | 1991-05-16 | 1995-03-07 | Rohm And Haas Company | HPLC avidin monomer affinity resin |
WO1997000329A2 (en) * | 1995-06-14 | 1997-01-03 | Yeda Research And Development Co. Ltd. | Modified avidin and streptavidin molecules and use thereof |
WO2000070073A1 (en) * | 1999-05-19 | 2000-11-23 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
WO2001051067A1 (en) * | 2000-01-13 | 2001-07-19 | Baxter International Inc. | Multiple inactivated blood factor anticoagulant composition |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022688A (en) * | 1996-05-13 | 2000-02-08 | Sequenom, Inc. | Method for dissociating biotin complexes |
-
2001
- 2001-02-01 GB GBGB0102568.3A patent/GB0102568D0/en not_active Ceased
-
2002
- 2002-02-01 AU AU2002228214A patent/AU2002228214B2/en not_active Ceased
- 2002-02-01 WO PCT/GB2002/000466 patent/WO2002061428A2/en active Application Filing
- 2002-02-01 CA CA2432538A patent/CA2432538C/en not_active Expired - Fee Related
- 2002-02-01 EP EP02710163A patent/EP1356290B1/en not_active Expired - Lifetime
- 2002-02-01 AT AT02710163T patent/ATE553379T1/en active
- 2002-02-01 US US10/470,846 patent/US7279285B2/en not_active Expired - Fee Related
- 2002-02-01 JP JP2002561943A patent/JP4394879B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0456304A1 (en) * | 1990-05-04 | 1991-11-13 | Johnson & Johnson Clinical Diagnostics, Inc. | Preparation and isolation of single-stranded biotinylated nucleic acids by avidin-biotin cleavage |
US5387505A (en) * | 1990-05-04 | 1995-02-07 | Eastman Kodak Company | Preparation and isolation of single-stranded biotinylated nucleic acids by heat avidin-biotin cleavage |
US5395856A (en) * | 1991-05-16 | 1995-03-07 | Rohm And Haas Company | HPLC avidin monomer affinity resin |
JPH0578369A (en) * | 1991-08-12 | 1993-03-30 | Mitsubishi Petrochem Co Ltd | Method for separating and recovering d-biotin |
WO1997000329A2 (en) * | 1995-06-14 | 1997-01-03 | Yeda Research And Development Co. Ltd. | Modified avidin and streptavidin molecules and use thereof |
WO2000070073A1 (en) * | 1999-05-19 | 2000-11-23 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
WO2001051067A1 (en) * | 2000-01-13 | 2001-07-19 | Baxter International Inc. | Multiple inactivated blood factor anticoagulant composition |
Non-Patent Citations (6)
Title |
---|
DATABASE WPI Section Ch Week 199317, Derwent World Patents Index; Class B02, AN 1993-140353, XP002226763 * |
DING ZHONGLI ET AL: "Temperature control of biotin binding and release with A streptavidin-poly(N-isopropylacrylamide) site-specific conjugate.", BIOCONJUGATE CHEMISTRY, vol. 10, no. 3, May 1999 (1999-05-01), pages 395 - 400, XP002226760, ISSN: 1043-1802 * |
FOULON C F ET AL: "Preparation and Biological Evaluation of an Astatine-211 Labeled Biotin Conjugate: Biotinyl-3-[At]astatoanilide", NUCLEAR MEDICINE AND BIOLOGY, ELSEVIER SCIENCE PUBLISHERS, NEW YORK, NY, US, vol. 24, no. 2, 1 February 1997 (1997-02-01), pages 135 - 143, XP004058584, ISSN: 0969-8051 * |
GARRET-FLAUDY F ET AL: "Use of the avidin (imino)biotin system as a general approach to affinity precipitation.", BIOTECHNOLOGY AND BIOENGINEERING. UNITED STATES 2000-2001, vol. 71, no. 3, 2000, pages 223 - 234, XP002226762, ISSN: 0006-3592 * |
GREEN N M ET AL: "The kinetics of biotin binding: The affinity for avidin.", BIOMOLECULAR ENGINEERING, vol. 16, no. 5, May 2000 (2000-05-01), First International Conference on;Alberta, Canada; June 18-21, 2000, pages 170, XP002226761, ISSN: 1389-0344 * |
MORRIS J E ET AL: "AFFINITY PRECIPITATION OF PROTEINS BY POLYLIGANDS", BIOTECHNOLOGY AND BIOENGINEERING, INTERSCIENCE PUBLISHERS, LONDON, GB, vol. 41, 1993, pages 991 - 997, XP001093626, ISSN: 0006-3592 * |
Also Published As
Publication number | Publication date |
---|---|
JP4394879B2 (en) | 2010-01-06 |
AU2002228214B2 (en) | 2007-01-04 |
EP1356290A2 (en) | 2003-10-29 |
EP1356290B1 (en) | 2012-04-11 |
GB0102568D0 (en) | 2001-03-21 |
CA2432538C (en) | 2012-03-20 |
JP2004527732A (en) | 2004-09-09 |
US20040077024A1 (en) | 2004-04-22 |
WO2002061428A2 (en) | 2002-08-08 |
WO2002061428A8 (en) | 2003-11-27 |
ATE553379T1 (en) | 2012-04-15 |
CA2432538A1 (en) | 2002-08-08 |
US7279285B2 (en) | 2007-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002061428A8 (en) | Method of disrupting interactions between biotin and biotin-binding compounds | |
WO2008140573A3 (en) | Methods for reversibly binding a biotin compound to a support | |
WO2002042486A3 (en) | Methods for detection of a nucleic acid by sequential amplification | |
WO2004046339A3 (en) | Caged sensors, regulators and compounds and uses thereof | |
WO2003046146A3 (en) | Compositions and methods of selective nucleic acid isolation | |
AU2001245945A1 (en) | Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof | |
WO2001092579A3 (en) | Methods for detecting target nucleic acids using coupled ligation and amplification | |
WO2006007567A3 (en) | Methods and compositions to detect nucleic acids in a biological sample | |
AU1348801A (en) | Methods for detection of a target nucleic acid sequence | |
WO2004104214A3 (en) | Methods and devices for multiplexing amplification reactions | |
WO1993015229A3 (en) | Amplification of assay reporters by nucleic acid replication | |
WO2005052127A3 (en) | Real-time detection of nucleic acids and proteins | |
WO2004020654A3 (en) | Solid phase based nucleic acid assays combining high affinity and high specificity | |
AU2003235894A1 (en) | Method of detecting target nucleic acid | |
AU2002238274A1 (en) | Method for the detection of nucleic acid molecules | |
WO2001088124A3 (en) | Method and reagent for the inhibition of erg | |
WO2004022769A3 (en) | Means of detecting neurodegenerative processes and applications of same | |
EP1612266A3 (en) | Prostaglandin reductase | |
WO2004046182A3 (en) | Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases | |
WO2002002795A3 (en) | Multiplex sequencing method | |
WO2008071385A8 (en) | Use of acetals for the isolation of nucleic acids | |
WO2002090619A3 (en) | Addition product, production and use thereof as corrosion inhibitor | |
WO2005063170A3 (en) | Methods of identifying immunoregulatory agents, immunoregulatory agents, and uses thereof | |
WO2006132657A3 (en) | Enzyme assay with nanowire sensor | |
WO2001031057A3 (en) | Double-strand nucleic acid probes and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2432538 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002228214 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002561943 Country of ref document: JP Ref document number: 10470846 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002710163 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002710163 Country of ref document: EP |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 32/2002 DUE TO A TECHNICAL PROBLEM AT THE TIME OF INTERNATIONAL PUBLICATION, SOME INFORMATION WAS MISSING (81). THE MISSING INFORMATION NOW APPEARS IN THE CORRECTED VERSION. |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |